| Literature DB >> 34677460 |
Bo-Rong Peng1,2, Kuei-Hung Lai3,4,5, Gene-Hsiang Lee6, Steve Sheng-Fa Yu7, Chang-Yih Duh8, Jui-Hsin Su2,8, Li-Guo Zheng2, Tsong-Long Hwang9,10,11,12, Ping-Jyun Sung2,8,13,14,15.
Abstract
Sponge-derived scalaranes are remarkable sesterterpenoids previously found to exhibit profound inhibitory effects against neutrophilic inflammation. In our current work, we constructed the metabolomic profile of marine sponge Lendenfeldia sp. for the first time using a tandem mass spectrometry (MS/MS) molecular networking approach. The results highlighted the rich chemical diversity of these scalaranes, motivating us to conduct further research to discover novel scalaranes targeting neutrophilic inflammation. MS- and NMR-assisted isolation and elucidation led to the discovery of seven new homoscalaranes, lendenfeldaranes K-Q (1-7), characterized by methylation at C-24, together with five known derivatives, lendenfeldarane B (8), 25-nor-24-methyl-12,24-dioxoscalar-16-en-22-oic acid (9), 24-methyl-12,24,25-trioxoscalar-16-en-22-oic acid (10), felixin B (11), and 23-hydroxy-20-methyldeoxoscalarin (12). Scalaranes 1-4 and 6-12 were assayed against superoxide anion generation and elastase release, which represented the neutrophilic inflammatory responses of respiratory burst and degranulation, respectively. The results indicated that 1-3 and 6-12 exhibited potential anti-inflammatory activities (IC50 for superoxide anion scavenging: 0.87~6.57 μM; IC50 for elastase release: 1.12~6.97 μM).Entities:
Keywords: Lendenfeldia; anti-neutrophilic inflammation; homoscalarane; molecular networking
Mesh:
Substances:
Year: 2021 PMID: 34677460 PMCID: PMC8541400 DOI: 10.3390/md19100561
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of lendenfeldaranes K–Q (1–7), lendenfeldarane B (8), 25-nor-24-methyl-12,24-dioxoscalar-16-en-22-oic acid (9), 24-methyl-12,24,25-trioxoscalar-16-en-22-oic acid (10), felixin B (11), 23-hydroxy-20-methyldeoxoscalarin (12), lendenfeldaranes C (13) and D (14), and felixin A (15).
Figure 2MS/MS molecular networking revealed the structural diversity of scalarane-type sesterterpenoids from marine sponge Lendenfeldia sp.
Figure 3Crystal structure and absolute configuration of 10 by X-ray diffraction.
1H and 13C NMR data for 24-homoscalaranes 1 and 2.
| 1 | 2 | |||
|---|---|---|---|---|
| Position | δH ( | δC Mult. b | δH ( | δC Mult. d |
| 1 | 2.12 m; 0.50 ddd (13.2, 13.2, 2.4) | 34.3, CH2 | 2.49 m; 0.67 ddd (12.8, 12.8, 3.2) | 38.4, CH2 |
| 2 | 1.54 m | 18.3, CH2 | 1.60 m | 18.6, CH2 |
| 3 | 1.42 m; 1.15 m | 41.7, CH2 | 1.39 m; 1.14 m | 42.2, CH2 |
| 4 | 33.0, C | 33.3, C | ||
| 5 | 0.96 m | 57.0, CH | 1.01 m | 56.4, CH |
| 6 | 1.94 m; 1.57 m | 17.0, CH2 | 1.93 m; 1.52 m | 16.9, CH2 |
| 7 | 1.93 m; 1.07 m | 42.0, CH2 | 1.94 m; 1.05 ddd (12.8, 12.8, 2.8) | 41.4, CH2 |
| 8 | 37.5, C | 37.7, C | ||
| 9 | 1.25 m | 53.4, CH | 1.45 m | 52.4, CH |
| 10 | 41.8, C | 47.6, C | ||
| 11 | 2.33 m; 2.17 m | 23.9, CH2 | 2.30 m; 1.83 m | 22.7, CH2 |
| 12 | 5.50 dd (3.0, 3.0) | 74.0, CH | 5.56 dd (2.8, 2.8) | 73.6, CH |
| 13 | 38.4, C | 38.2, C | ||
| 14 | 1.56 m | 51.2, CH | 1.51 m | 50.9, CH |
| 15 | 2.35 m | 24.0, CH2 | 2.34 m; 2.20 m | 23.9, CH2 |
| 16 | 1.57 m; 1.44 m | 17.9, CH2 | 1.48 m | 20.2, CH2 |
| 17 | 163.6, C | 163.7, C | ||
| 18 | 132.7, C | 132.5, C | ||
| 19 | 0.87 s | 33.8, CH3 | 0.92 s | 33.8, CH3 |
| 20 | 0.77 s | 21.8, CH3 | 0.86 s | 22.4, CH3 |
| 21 | 1.09 s | 16.3, CH3 | 0.85 s | 14.4, CH3 |
| 22 | 4.03 d (12.0); 3.87 dd (12.0, 1.2) | 62.8, CH2 | 178.8, C | |
| 23 | 1.19 s | 21.1, CH3 | 1.13 s | 21.2, CH3 |
| 24 | 4.77 q (6.6) | 77.6, CH | 4.77 q (6.8) | 77.7, CH |
| 25 | 171.0, C | 170.9, C | ||
| 26 | 1.36 d (6.6) | 18.7, CH3 | 1.35 d (6.8) | 18.6, CH3 |
| OAc-12 | 169.9, C | 169.8, C | ||
| 1.96 s | 21.2, CH3 | 1.96 s | 21.2, CH3 | |
a 600 MHz in CDCl3, b 150 MHz in CDCl3, c 400 MHz, CDCl3, d 100 MHz, CDCl3.
Figure 4Key COSY (), HMBC (), and protons with NOESY () correlations of 1.
Figure 5Key COSY (), HMBC (), and protons with NOESY () correlations of 2.
1H and 13C NMR data for 24-homoscalaranes 3 and 4.
| 3 | 4 | |||
|---|---|---|---|---|
| Position | δH ( | δC Mult. b | δH ( | δC Mult. b |
| 1 | 2.52 m; 0.94 m | 38.3, CH2 | 2.01 m; 0.51 ddd (12.4, 12.4, 4.4) | 34.7, CH2 |
| 2 | 2.30 m; 1.60 m | 16.6, CH2 | 1.58 m | 18.2, CH2 |
| 3 | 1.41 m; 1.16 m | 42.2, CH2 | 1.44 m; 1.13 m | 41.5, CH2 |
| 4 | 33.4, C | 33.0, C | ||
| 5 | 1.12 m | 56.1, CH | 1.01 m | 57.1, CH |
| 6 | 1.91 m; 1.54 m | 18.6, CH2 | 1.58 m; 1.45 m | 18.0, CH2 |
| 7 | 1.92 m; 1.10 m | 41.3, CH2 | 1.93 m; 1.11 m | 41.8, CH2 |
| 8 | 37.8, C | 37.4, C | ||
| 9 | 1.77 m | 51.5, CH | 1.31 m | 53.2, CH |
| 10 | 47.8, C | 40.1, C | ||
| 11 | 1.99 m; 1.89 m | 25.8, CH2 | 2.20 m; 2.03 m | 23.3, CH2 |
| 12 | 4.65 br s | 69.7, CH | 5.49 br s | 73.9, CH |
| 13 | 40.1, C | 38.5, C | ||
| 14 | 1.55 m | 49.8, CH | 1.53 m | 51.3, CH |
| 15 | 2.26 m | 24.3, CH2 | 2.48 m; 2.35 m | 22.8, CH2 |
| 16 | 1.53 m; 1.42 m | 20.2, CH2 | 1.42 m | 18.1, CH2 |
| 17 | 165.4, C | 161.6, C | ||
| 18 | 133.1, C | 134.3, C | ||
| 19 | 0.92 s | 33.7, CH3 | 0.88 s | 33.7, CH3 |
| 20 | 0.88 s | 22.4, CH3 | 0.83 s | 21.8, CH3 |
| 21 | 0.85 s | 14.3, CH3 | 0.97 s | 16.4, CH3 |
| 22 | 179.3, C | 4.58 d (12.0); 4.14 d (12.0) | 64.7, CH2 | |
| 23 | 1.09 s | 21.5, CH3 | 1.21 s | 21.1, CH3 |
| 24 | 4.78 q (6.8) | 78.6, CH | 103.4, C | |
| 25 | 172.5, C | 178.1, C | ||
| 26 | 1.36 d (6.8) | 18.4, CH3 | 1.59 s | 24.3, CH3 |
| OAc-12 | 169.6, C | |||
| 1.95 s | 21.2, CH3 | |||
| OAc-22 | 171.0, C | |||
| 2.06 s | 21.2, CH3 | |||
a 400 MHz in CDCl3, b 100 MHz in CDCl3.
Figure 6Key COSY (), HMBC (), and protons with NOESY () correlations of 3.
Figure 7Key COSY (), HMBC (), and protons with NOESY () correlations of 4.
1H and 13C NMR data for 24-homoscalaranes 5 and 6.
| 5 | 6 | |||
|---|---|---|---|---|
| Position | δH ( | δC Mult. b | δH ( | δC Mult. b |
| 1 | 2.11 m; 0.53 ddd (14.4, 14.4, 4.8) | 34.3, CH2 | 2.12 m; 0.53 ddd (13.2, 13.2, 2.4) | 34.4, CH2 |
| 2 | 1.54 m; 1.39 m | 18.0, CH2 | 1.53 m | 17.8, CH2 |
| 3 | 1.44 m; 1.20 m | 41.7, CH2 | 1.45 m; 1.18 m | 41.7, CH2 |
| 4 | 33.0, C | 33.0, C | ||
| 5 | 1.02 dd (12.6, 2.4) | 56.7, CH | 0.98 dd (12.6, 2.4) | 56.9, CH |
| 6 | 1.47 m | 18.2, CH2 | 1.55 m; 1.48 m | 18.4, CH2 |
| 7 | 1.82 ddd (12.6, 3.0, 3.0); 1.20 m | 41.9, CH2 | 1.80 ddd (12.6, 3.0, 3.0); 1.06 m | 41.9, CH2 |
| 8 | 37.2, C | 37.4, C | ||
| 9 | 1.35 br d (12.6) | 53.0, CH | 1.34 m | 52.5, CH |
| 10 | 41.7, C | 41.7, C | ||
| 11 | 2.20 m; 1.98 m | 26.0, CH2 | 2.10 m; 2.00 m | 25.0, CH2 |
| 12 | 4.92 dd (3.0, 3.0) | 79.7, CH | 5.01 dd (3.6, 2.4) | 73.6, CH |
| 13 | 39.2, C | 40.1, C | ||
| 14 | 2.23 m | 42.0, CH | 1.52 m | 47.8, CH |
| 15 | 1.25 m | 29.6, CH2 | 2.26 m | 24.3, CH2 |
| 16 | 6.99 br s | 143.6, CH | 6.88 br s | 141.8, CH |
| 17 | 132.2, C | 140.0, C | ||
| 18 | 4.38 s | 70.9, CH | 4.57 s | 69.7, CH |
| 19 | 0.89 s | 33.8, CH3 | 0.87 s | 33.8, CH3 |
| 20 | 0.77 s | 22.0, CH3 | 0.77 s | 21.9, CH3 |
| 21 | 1.11 s | 15.5, CH3 | 1.15 s | 15.8, CH3 |
| 22 | 4.05 d (10.8); 3.91 dd (10.8, 4.8) | 62.9, CH2 | 4.04 d (12.0); 3.89 dd (12.0, 1.2) | 63.0, CH2 |
| 23 | 0.70 s | 19.7, CH3 | 0.94 s | 12.6, CH3 |
| 24 | 197.8, C | 202.2, C | ||
| 25 | 2.32 s | 24.8, CH3 | 2.32 s | 26.1, CH3 |
| OAc-12 | 169.2, C | 170.1, C | ||
| 2.14 s | 22.0, CH3 | 2.11 s | 21.5, CH3 | |
| 18-OH | 4.11 d (1.8) | |||
a 600 MHz in CDCl3, b 150 MHz in CDCl3.
Figure 8Key COSY (), HMBC (), and protons with NOESY () correlations of 5.
Figure 9Key COSY (), HMBC (), and protons with NOESY () correlations of 6.
1H and 13C NMR data for 24-homoscalarane 7.
| Position | δH ( | δC Mult. b |
|---|---|---|
| 1 | 2.47 m; 0.91 m | 38.3, CH2 |
| 2 | 1.54 m | 20.1, CH2 |
| 3 | 1.40 m; 1.16 m | 42.0, CH2 |
| 4 | 33.4, C | |
| 5 | 1.06 m | 56.2, CH |
| 6 | 2.31 m; 1.65 m | 18.4, CH2 |
| 7 | 2.00 m; 1.13 m | 40.6, CH2 |
| 8 | 37.3, C | |
| 9 | 1.61 m | 58.5, CH |
| 10 | 48.7, C | |
| 11 | 2.87 dd (14.4, 14.4); 2.67 dd (14.4, 2.8) | 36.5, CH2 |
| 12 | 210.3, C | |
| 13 | 50.3, C | |
| 14 | 1.70 m | 48.7, CH |
| 15 | 1.96 m; 1.73 m | 25.1, CH2 |
| 16 | 4.57 dd (4.0, 1.6) | 63.2, CH |
| 17 | 137.7, C | |
| 18 | 7.40 s | 147.2, CH |
| 19 | 0.91 s | 33.7, CH3 |
| 20 | 0.88 s | 22.5, CH3 |
| 21 | 1.03 s | 14.3, CH3 |
| 22 | 179.3, C | |
| 23 | 1.20 s | 19.8, CH3 |
| 24 | 201.8, C | |
| 25 | 2.36 s | 25.7, CH3 |
a 400 MHz in CDCl3, b 100 MHz in CDCl3.
Figure 10Key COSY (), HMBC (), and protons with NOESY () correlations of 7.
Anti-inflammatory activities of isolated compounds 1–4 and 6–12.
| Compound | Superoxide Anion generation | Elastase Release | ||
|---|---|---|---|---|
| IC50 (μM) a | Inh % | IC50 (μM) a | Inh % | |
|
| 0.87 ± 0.14 | 98.90 ± 0.79 *** | 1.12 ± 0.37 | 101.69 ± 2.91 *** |
|
| 1.11 ± 0.10 | 101.77 ± 1.05 *** | 1.65 ± 0.31 | 91.46 ± 5.24 *** |
|
| 6.57 ± 0.67 | 70.78 ± 5.80 *** | 48.78 ± 3.17 *** | |
|
| 34.63 ± 6.30 ** | 42.52 ± 5.88 ** | ||
|
| 1.75 ± 0.02 | 97.57 ± 1.42 *** | 1.59 ± 0.41 | 102.08 ± 0.44 *** |
|
| 6.25 ± 1.17 | 71.74 ± 8.89 *** | 45.82 ± 6.54 ** | |
|
| 1.47 ± 0.24 | 101.35 ± 0.77 *** | 2.78 ± 0.78 | 101.83 ± 2.28 *** |
|
| 1.50 ± 0.08 | 97.27 ± 1.59 *** | 1.74 ± 0.15 | 101.80 ± 3.06 *** |
|
| 2.83 ± 0.63 | 98.94 ± 0.60 *** | 1.66 ± 0.09 | 93.47 ± 4.73 *** |
|
| 6.33 ± 0.89 | 69.61 ± 6.49 *** | 48.06 ± 5.55 *** | |
|
| 44.48 ± 6.95 ** | 6.97 ± 1.01 | 101.69 ± 8.13 *** | |
Percentage of inhibition (Inh %) at 10 μM. Results are presented as the mean ± S.E.M. (n = 3~5). ** p < 0.01, *** p < 0.001 compared with the control (DMSO). a Concentration necessary for 50% inhibition (IC50).